UniBio
Niigata
About UniBio
UniBio is an aim to produce useful proteins in plants using biotechnology called the transient gene expression method.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2024)
- Website: unibio-jp.com
- Phone: +81 0256-78-8120
Industries & Categories
Biopharma, Biotechnology, Product Research
Canonical: https://fsome.com/organization/unibio-101195 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.